薛瑜;王鸥;邢小平;

• 1:中国医学科学院北京协和医学院北京协和医院内分泌科卫生部内分泌重点实验室

摘要(Abstract)：

<正>原发性甲状旁腺功能亢进症(primary hyperparathyroidism,PHPT)指由于甲状旁腺组织原发异常引起的甲状旁腺激素(parathyroid hormone,PTH)合成分泌过多,通过作用于骨、肾脏和小肠等靶器官,导致高钙血症、低磷血症、骨代谢异常及泌尿系结石等的一组临床症候群。该病在西方国家内分泌疾病中患病率居第3位,仅次于糖尿病和甲状腺疾病[1-2];国

关键词(KeyWords)： 原发性甲状旁腺功能亢进症;维生素D缺乏;术前维生素D补充

Abstract:

Keywords:

基金项目(Foundation): 国家自然科学基金青年基金(81100559)和面上项目(81270873)

作者(Authors): 薛瑜;王鸥;邢小平;

参考文献(References)：

• [1]Fraser WD.Hyperparathyroidism[J].Lancet,2009,374:145-158.
• [2]Pallan S,Khan A.Primary hyperparathyroidism:update on presentation,diagnosis,and management in primary care[J].Can Fam Physician,2011,57:184-189.
• [3]Orwoll E,Nielson CM,Marshall LM,et al.Vitamin D deficiency in older men[J].J Clin Endocrinol Metab,2009,94:1214-1222.
• [4]Forrest KY,Stuhldreher WL.Prevalence and correlates of vitamin D deficiency in US adults[J].Nutr Res,2011,31:48-54.
• [5]Jacques PF,Felson DT,Tucker KL,et al.Plasma 25-hydroxyvitamin D and its determinants in an elderly population sample[J].Am J Clin Nutr,1997,66:929-936.
• [6]Looker AC,Pfeiffer CM,Lacher DA,et al.Serum 25-hydroxyvitamin D status of the US population:1988-1994compared with 2000-2004[J].Am J Clin Nutr,2008,88:1519-1527.
• [7]Chapuy MC,Pamphile R,Paris E,et al.Combined calcium and vitamin D3supplementation in elderly women:confirma-tion of reversal of secondary hyperparathyroidism and hip fracture risk:the Decalyos II study[J].Osteoporos Int,2002,13:257-264.
• [8]Tribedi DP,Doll R,Khaw KT.Effect of four monthly oral vitamin D3(cholecalciferol)supplementation on fractures and mortality in men and women living in the community:randomized double blind controlled trial[J].BMJ,2003,326:469.
• [9]Sanders KM,Stuart AL,Williamson EJ,et al.Annual highdose oral vitamin D and falls and fractures in older women:a randomized controlled trial[J].JAMA,2010,303:1815-1822.
• [10]Dawson-Hughes B,Mithal A,Bonjour JP,et al.IOF position statement:vitamin D recommendations for older adults[J].Osteoporos Int,2010,21:1151-1154.
• [11]Holick MF,Binkley NC,Bischoff-Ferrari HA,et al.Evaluation,treatment,and prevention of vitamin D deficiency:an Endocrine Society clinical practice guideline[J].J Clin Endocrinol Metab,2011,96:1911-1930.
• [12]Holick MF.High prevalence of vitamin D inadequacy and implications for health[J].Mayo Clin Proc,2006,81:353-373.
• [13]Vieth R.What is the optimal vitamin D status for health?[J].Prog Biophys Mol Biol,2006,92:26-32.
• [14]Silverberg SJ,Shane E,Dempster DW,et al.The effects of vitamin D insufficiency in patients with primary hyperparathyroidism[J].Am J Med,1999,107:561-567.
• [15]Saliba W,Lavi I,Rennert HS,et al.Vitamin D status in primary hyperparathyroidism[J].Eur J Intern Med,2012,23:88-92.
• [16]Moosgaard B,Vestergaard P,Heickendorff L,et al.Vitamin D status,seasonal variations,parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism[J].Clin Endocrinol,2005,63:506-513.
• [17]Clements MR,Davies M,Hayes ME,et al.The role of 1,25-dihydroxyvitamin D in the mechanism of acquired vitamin D deficiency[J].Clin Endocrinol,1992,37:17-27.
• [18]Clements MR,Davies M,Fraser DR,et al.Metabolic inactivation of vitamin D is enhanced in primary hyperparathyroidism[J].Clin Sci,1987,73:659-664.
• [19]Moosgaard B,Christensen SE,Vestergaard P,et al.Vitamin D metabolites and skeletal consequences in primary hyperparathyroidism[J].Clin Endocrinol,2008,68:707-715.
• [20]Carnevale V,Manfredi G,Romagnoli E,et al.Vitamin D status in female patients with primary hyperparathyroidism:does it play a role in skeletal damage?[J].Clin Endocrinol,2004,60:81-86.
• [21]Velayoudom-Cephise FL,Foucan L,Soudan B,et al.Half of the patients with primary hyperparathyroidism have a vitamin D deficiency:aggravating the osseous attack[J].Presse Med,2011,40:e120-e127.
• [22]Rao DS,Honasoge M,Divine GW,et al.Effect of vitamin D nutrition on parathyroid adenoma weight:pathogenetic and clinical implications[J].J Clin Endocrinol Metab,2000,85:1054-1058.
• [23]Ozbey N,Erbil Y,Ademoglu E,et al.Correlations between vitamin D status and biochemical/clinical and pathological parameters in primary hyperparathyroidism[J].World J Surg,2006,30:321-326.
• [24]Grubbs EG,Rafeeq S,Jimenez C,et al.Preoperative vitamin D replacement therapy in primary hyperparathyroidism:safe and beneficial?[J].Surgery,2008,144:852-858.
• [25]Brown EM.Four-parameter model of the sigmoidal relationship between parathyroid hormone release and extracellular calcium concentration in normal and abnormal parathyroid tissue[J].J Clin Endocrinol Metab,1983,56:572-581.
• [26]Kantorovich V,Gacad MA,Seeger LL,et al.Bone mineral density increases with vitamin D repletion in patients with coexistent vitamin D insufficiency and primary hyperparathyroidism[J].J Clin Endocrinol Metab,2000,85:3541-3543.
• [27]Grey A,Lucas J,Horne A,et al.Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency[J].J Clin Endocrinol Metab,2005,90:2122-2126.
• [28]Tucci JR.Vitamin D therapy in patients with primary hyperparathyroidism and hypovitaminosis D[J].Eur J Endocrinol,2009,161:189-193.
• [29]Isidro ML,Ruano B.Biochemical effects of calcifediol supplementation in mild,asymptomatic,hyperparathyroidism with concomitant vitamin D deficiency[J].Endocrine,2009,36:305-310.
• [30]Rao RR,Randeva HS,Sankaranarayanan S,et al.Prolonged treatment with vitamin D in postmenopausal women with primary hyperparathyroidism[J].Endocr Connect,2012,1:13-21.
• [31]Wagner D,Xia Y,Hou R.Safety of vitamin D replacement in patients with primary hyperparathyroidism and concomitant vitamin D deficiency[J].Endocr Pract,2013,19:420-425.
• [32]Rathi MS,Gonzalez S,Wright D,et al.Management of hypovitaminosis D in patients with primary hyperparathyroidism[J].J Endocrinol Invest,2014,37:467-471.
• [33]Rolighed L,Rejnmark L,Sikjaer T,et al.Vitamin D treatment in primary hyperparathyroidism:a randomized placebo controlled trial[J].J Clin Endocrinol Metab,2014,99:1072-1080.
• [34]Das G,Eligar V,Govindan J,et al.Impact of vitamin D replacement in patients with normocalcaemic and hypercalcaemic primary hyperparathyroidism and coexisting vitamin D deficiency[J].Ann Clin Biochem,2015,52:462-469.